İmmünoterapi ve Hedefe Yönelik Tedavilerde Perioperatif Cerrahi Yönetim

Björkström K, Matikas A, Svedman FC, et al. Perioperative immune checkpoint inhibitor therapy across tumors: Insights and shared lessons from a rapidly evolving field. Journal of Internal Medicine. 2026;299(5):538-569. doi:10.1111/joim.70073

Forde PM, Spicer J, Lu S, et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. New England Journal of Medicine. 2022;386(21):1973-1985. doi:10.1056/NEJMoa2202170

Cascone T, Awad MM, Spicer JD, et al. Perioperative nivolumab in resectable lung cancer. New England Journal of Medicine. 2024;390(19):1756-1769. doi:10.1056/NEJMoa2311926

Schmid P, Cortes J, Dent R, et al. Event-free survival with pembrolizumab in early triple-negative breast cancer. New England Journal of Medicine. 2022;386(6):556-567. doi:10.1056/NEJMoa2112651

Blank CU, Lucas MW, Scolyer RA, et al. Neoadjuvant nivolumab and ipilimumab in resectable stage III melanoma. New England Journal of Medicine. 2024;391(18):1696-1708. doi:10.1056/NEJMoa2402604

Chalabi M, Verschoor YL, Batista Tan P, et al. Neoadjuvant immunotherapy in locally advanced mismatch repair-deficient colon cancer. New England Journal of Medicine. 2024;390(21):1949-1958. doi:10.1056/NEJMoa2400634

Nahm WJ, Falanga V. The adverse impact of tyrosine kinase inhibitors on wound healing and repair. International Wound Journal. 2025;22(4):e70513. doi:10.1111/iwj.70513

Scappaticci FA, Fehrenbacher L, Cartwright T, et al. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. Journal of Surgical Oncology. 2005;91(3):173-180. doi:10.1002/jso.20301

U.S. National Library of Medicine. DailyMed: AVASTIN (bevacizumab) injection, solution - prescribing information. (24/08/2026 tarihinde https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=939b5d1f-9fb2-4499-80ef-0607aa6b114e adresinden ulaşılmıştır).

Lewis AL, Chaft J, Girotra M, et al. Immune checkpoint inhibitors: a narrative review of considerations for the anaesthesiologist. British Journal of Anaesthesia. 2020;124(3):251-260. doi:10.1016/j.bja.2019.11.034

Bezu L, Akçal Öksüz D, Bell M, et al. Perioperative immunosuppressive factors during cancer surgery: an updated review. Cancers. 2024;16(13):2304. doi:10.3390/cancers16132304

Wilkinson HN, Hardman MJ. Wound healing: cellular mechanisms and pathological outcomes. Open Biology. 2020;10(9):200223. doi:10.1098/rsob.200223

Schneider BJ, Naidoo J, Santomasso BD, et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update. Journal of Clinical Oncology. 2021;39(36):4073-4126. doi:10.1200/JCO.21.01440

U.S. National Library of Medicine. DailyMed: CABOMETYX (cabozantinib) tablet - prescribing information. (24/08/2026 tarihinde https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3850cce2-6137-42e5-a792-d318c4a4b3b5 adresinden ulaşılmıştır).

U.S. National Library of Medicine. DailyMed: VOTRIENT (pazopanib hydrochloride) tablet, film coated - prescribing information. (24/08/2026 tarihinde https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7 adresinden ulaşılmıştır).

U.S. National Library of Medicine. DailyMed: NEXAVAR (sorafenib) tablet, film coated - prescribing information. (24/08/2026 tarihinde https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b50667e4-5ebc-4968-a646-d605058dbef0 adresinden ulaşılmıştır).

U.S. National Library of Medicine. DailyMed: SUTENT (sunitinib malate) capsule - prescribing information. (24/08/2026 tarihinde https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c adresinden ulaşılmıştır).

U.S. National Library of Medicine. DailyMed: LENVIMA (lenvatinib) capsule - prescribing information. (24/08/2026 tarihinde https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f4bedd21-efde-44c6-9d9c-b48b78d7ed1e adresinden ulaşılmıştır).

U.S. National Library of Medicine. DailyMed: INLYTA (axitinib) tablet - prescribing information. (24/08/2026 tarihinde https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84137882-e000-47da-bd5b-fa76ab3c76f9 adresinden ulaşılmıştır).

U.S. National Library of Medicine. DailyMed: STIVARGA (regorafenib) tablet - prescribing information. (24/08/2026 tarihinde https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=824f19c9-0546-4a8a-8d8f-c4055c04f7c7 adresinden ulaşılmıştır).

U.S. National Library of Medicine. DailyMed: FOTIVDA (tivozanib) capsule - prescribing information. (24/08/2026 tarihinde https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de77155c-ecf2-4f15-9758-21d271449d83 adresinden ulaşılmıştır).

U.S. National Library of Medicine. DailyMed: FRUZAQLA (fruquintinib) capsule - prescribing information. (24/08/2026 tarihinde https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=186d786e-dc8a-45f2-b5e1-01ac0201879f adresinden ulaşılmıştır).

Bott MJ, Yang SC, Park BJ, et al. Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery. 2019;158(1):269-276. doi:10.1016/j.jtcvs.2018.11.124